<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:18:05Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10434937" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10434937</identifier>
        <datestamp>2023-08-18</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLOS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10434937</article-id>
              <article-id pub-id-type="pmcid">PMC10434937</article-id>
              <article-id pub-id-type="pmc-uid">10434937</article-id>
              <article-id pub-id-type="pmid">37590237</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0289987</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-23-18402</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Study Protocol</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pediatrics</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Health Care</subject>
                    <subj-group>
                      <subject>Caregivers</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Clinical Medicine</subject>
                    <subj-group>
                      <subject>Clinical Trials</subject>
                      <subj-group>
                        <subject>Randomized Controlled Trials</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pharmacology</subject>
                    <subj-group>
                      <subject>Drug Research and Development</subject>
                      <subj-group>
                        <subject>Clinical Trials</subject>
                        <subj-group>
                          <subject>Randomized Controlled Trials</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Clinical Trials</subject>
                    <subj-group>
                      <subject>Randomized Controlled Trials</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Sociology</subject>
                    <subj-group>
                      <subject>Human Families</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Pediatric Infections</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pediatrics</subject>
                    <subj-group>
                      <subject>Pediatric Infections</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Bioengineering</subject>
                    <subj-group>
                      <subject>Biotechnology</subject>
                      <subj-group>
                        <subject>Medical Devices and Equipment</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Engineering and Technology</subject>
                  <subj-group>
                    <subject>Bioengineering</subject>
                    <subj-group>
                      <subject>Biotechnology</subject>
                      <subj-group>
                        <subject>Medical Devices and Equipment</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Devices and Equipment</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune Suppression</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune Suppression</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Clinical Medicine</subject>
                    <subj-group>
                      <subject>Signs and Symptoms</subject>
                      <subj-group>
                        <subject>Immune Suppression</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Improving medication adherence monitoring and clinical outcomes through mHealth: A randomized controlled trial protocol in pediatric stem cell transplant</article-title>
                <alt-title alt-title-type="running-head">Medication adherence monitoring and clinical outcomes through mHealth: A randomized controlled trial protocol</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ralph</surname>
                    <given-names>Jessica E.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8798-9605</contrib-id>
                  <name>
                    <surname>Sezgin</surname>
                    <given-names>Emre</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9937-0743</contrib-id>
                  <name>
                    <surname>Stanek</surname>
                    <given-names>Charis J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3319-5652</contrib-id>
                  <name>
                    <surname>Landier</surname>
                    <given-names>Wendy</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pai</surname>
                    <given-names>Ahna L. H.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gerhardt</surname>
                    <given-names>Cynthia A.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6786-8128</contrib-id>
                  <name>
                    <surname>Skeens</surname>
                    <given-names>Micah A.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>The Ohio State University College of Medicine, Columbus, Ohio, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>University of Alabama Birmingham School of Medicine, Birmingham, Alabama, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Cincinnati Children’s Hospital Medical Center &amp; University of Cincinnati, Cincinnati, Ohio, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Ali</surname>
                    <given-names>Richard</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>UNITED KINGDOM</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>Micah.Skeens@nationwidechildrens.org</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>17</day>
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <volume>18</volume>
              <issue>8</issue>
              <elocation-id>e0289987</elocation-id>
              <history>
                <date date-type="received">
                  <day>11</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>25</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2023 Ralph et al</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Ralph et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0289987.pdf"/>
              <abstract>
                <p>Medication non-adherence rates in children range between 50% and 80% in the United States. Due to multifaceted outpatient routines, children receiving hematopoietic stem cell transplant (HCT) are at especially high risk of non-adherence, which can be life-threatening. Although digital health interventions have been effective in improving non-adherence in many pediatric conditions, limited research has examined their benefits among families of children receiving HCT. To address this gap, we created the BMT4me© mobile health app, an innovative intervention serving as a “virtual assistant” to send medication-taking reminders for caregivers and to track, in real-time, the child’s medication taking, barriers to missed doses, symptoms or side effects, and other notes regarding their child’s treatment. In this randomized controlled trial, caregivers will be randomized to either the control (standard of care) group or the intervention (BMT4me© app) group at initial discharge post-HCT. Both groups will receive an electronic adherence monitoring device (i.e., medication event monitoring system “MEMS” cap, Medy Remote Patient Management “MedyRPM” medication adherence box) to store their child’s immunosuppressant medication. Caregivers who agree to participate will be asked to complete enrollment, weekly, and monthly parent-proxy measures of their child’s medication adherence until the child reaches Day 100 or complete taper from immunosuppression. Caregivers will also participate in a 15 to 30-minute exit interview at the conclusion of the study. Descriptive statistics and correlations will be used to assess phone activity and use behavior over time. Independent samples t-tests will examine the efficacy of the intervention to improve adherence monitoring and reduce readmission rates. The primary expected outcome of this study is that the BMT4me© app will improve the real-time monitoring and medication adherence in children receiving hematopoietic stem cell transplant following discharge, thus improving clinical outcomes.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000056</institution-id>
                      <institution>National Institute of Nursing Research</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K99NR019115</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6786-8128</contrib-id>
                    <name>
                      <surname>Skeens</surname>
                      <given-names>Micah A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000056</institution-id>
                      <institution>National Institute of Nursing Research</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R00NR019115</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6786-8128</contrib-id>
                    <name>
                      <surname>Skeens</surname>
                      <given-names>Micah A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>The Oncology Nursing Foundation (<ext-link xlink:href="https://www.onfgivesback.org/contact" ext-link-type="uri">https://www.onfgivesback.org/contact</ext-link>) and National Institute of Health/Nursing (<ext-link xlink:href="https://www.nih.gov/" ext-link-type="uri">https://www.nih.gov/</ext-link>) supported the mHealth app prototype development (K99NR019115). This study is supported by the National Institute of Health/Nursing (R00NR019115). M.S. received both of these awards. The funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="1"/>
                <page-count count="13"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Poor adherence accounts for up to 70% of all medication-related hospital admissions [<xref rid="pone.0289987.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0289987.ref002" ref-type="bibr">2</xref>] in the United States, resulting in approximately $100 billion in healthcare costs annually [<xref rid="pone.0289987.ref003" ref-type="bibr">3</xref>]. Non-adherence rates have been reported as high as 50–80% in pediatric chronic illness populations [<xref rid="pone.0289987.ref004" ref-type="bibr">4</xref>–<xref rid="pone.0289987.ref006" ref-type="bibr">6</xref>]. and 51 to 66% in adult hematopoietic stem cell transplant (HCT) patients [<xref rid="pone.0289987.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0289987.ref008" ref-type="bibr">8</xref>]. A growing body of evidence in chronic illnesses suggestst non-adherence is associated with adverse clinical outcomes, including infectious complications, hospital admissions, and even death [<xref rid="pone.0289987.ref009" ref-type="bibr">9</xref>–<xref rid="pone.0289987.ref012" ref-type="bibr">12</xref>]. However, the impact of non-adherence on pediatric HCT clinical outcomes is largely unknown.</p>
              <p>Hematopoietic stem cell transplant patients are most immunocompromised during the first 100 days [<xref rid="pone.0289987.ref013" ref-type="bibr">13</xref>], thus during this time, HCT recipients must adhere to multifaceted and complex outpatient medication regimens. Specifically, adherence to immunosuppressant medications during the acute phase (first 100 days) post-transplant is critical to prevent graft versus host disease (GVHD) and avoid graft failure [<xref rid="pone.0289987.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0289987.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0289987.ref015" ref-type="bibr">15</xref>]. Children that develop acute GVHD have a 30% to 50% chance of survival. Morbidity and mortality due to GVHD can be decreased through prophylactic use of immunosuppressants [<xref rid="pone.0289987.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0289987.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0289987.ref017" ref-type="bibr">17</xref>]. Although these medications are costly and produce unpleasant side effects [<xref rid="pone.0289987.ref014" ref-type="bibr">14</xref>], adherence is critical to decrease complications, reduce readmissions, and ultimately increase quality of life and survival [<xref rid="pone.0289987.ref010" ref-type="bibr">10</xref>].</p>
              <p>The complexity and duration of treatment regimens, along with forgetfulness, have been consistently identified as the primary determinants of medication non-adherence [<xref rid="pone.0289987.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0289987.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0289987.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0289987.ref018" ref-type="bibr">18</xref>–<xref rid="pone.0289987.ref020" ref-type="bibr">20</xref>]. Specifically, reasons for pediatric non-adherence are multifactorial and encompass various factors [<xref rid="pone.0289987.ref020" ref-type="bibr">20</xref>–<xref rid="pone.0289987.ref022" ref-type="bibr">22</xref>] As primary caregivers, they are responsible for filling prescriptions, retrieving medications, and ensuring their child receives the prescribed therapy correctly [<xref rid="pone.0289987.ref023" ref-type="bibr">23</xref>–<xref rid="pone.0289987.ref025" ref-type="bibr">25</xref>]. In the high-risk HCT population, caregivers are isolated with their child due to infection risk and must manage challenging treatment regimens at home, often with limited time and support. Complex behavioral interventions, typically employed to address non-adherence, are difficult to deliver and manage in the context of these daily tasks, especially when one considers the geographic, resource, and time constraints families of chronically ill children face [<xref rid="pone.0289987.ref026" ref-type="bibr">26</xref>].</p>
              <p>mHealth apps offer solutions to address non-adherence, reduce potential barriers, and are widely available, simple, and innovative [<xref rid="pone.0289987.ref027" ref-type="bibr">27</xref>–<xref rid="pone.0289987.ref032" ref-type="bibr">32</xref>]. However, their feasibility, acceptability, and usability, especially in pediatric care, remain uncertain. Recent reviews of pediatric medical adherence apps found that none identified individual barriers to adherence [<xref rid="pone.0289987.ref033" ref-type="bibr">33</xref>] and, specific to the pediatric oncology population, nearly all were designed solely for education or nonmedication-related purposes [<xref rid="pone.0289987.ref034" ref-type="bibr">34</xref>]. Similarly, to the best of our knowledge, limited applications and research exist regarding adherence in pediatric HCT, and broad gaps exist with regard to adherence to immunosuppressant medication.</p>
              <p>To address these gaps, this longitudinal, pilot RCT protocol reports the design and methods of a preliminary acceptability and efficacy study of the BMT4me© mobile health app (referred to hereinafter as the “BMT4me© app”), as well as the feasibility of enrolling and retaining 50 caregivers of children during the acute, outpatient phase (i.e., first 100 days) post-HCT.</p>
              <sec id="sec002">
                <title>Hypotheses</title>
                <p>We hypothesize caregivers enrolled in this study will: (a) report above average acceptability (≥ 68%) of the BMT4me<italic toggle="yes">©</italic> app, and ≥ 75% of participants will enroll and complete all study-related assessments in both arms, (b) have higher adherence frequency, if randomized to the BMT4me<italic toggle="yes">©</italic> app, than the standard of care group, and (c) have less GVHD and fewer readmissions than the standard of care group.</p>
              </sec>
            </sec>
            <sec sec-type="materials|methods" id="sec003">
              <title>Methods</title>
              <sec id="sec004">
                <title>Design</title>
                <p>This is a longitudinal pilot randomized controlled trial (RCT) designed to test the efficacy of the BMT4me© app intervention on adherence to immunosuppressant medication in families of children discharged during the acute phase post-HCT. This study will take place at Nationwide Children’s Hospital (NCH), a large, academic, free-standing pediatric hospital in the Midwestern United States. Children and primary caregivers will be screened for eligibility during HCT, and caregivers of eligible participants will be approached regarding the study prior to the child’s discharge from the hospital. Participating families will be randomized (1:1) to either the standard of care control group or the BMT4me© app intervention group. Families in both groups will be assigned medication adherence monitoring devices and complete follow-up assessments once per week during the acute phase (i.e., approximately 11 weeks or 100 days) or until the child completes their immunosuppression medication taper. The objective of this RCT is to evaluate the acceptability of the newly developed BMT4me© app and the feasibility of enrolling and retaining 50 caregivers of children in the acute phase post-HCT. The secondary objective is to evaluate the potential efficacy of the BMT4me© app on adherence to immunosuppressant medications in children who have been discharged home during the acute phase post-HCT.</p>
              </sec>
              <sec id="sec005">
                <title>Setting and participants</title>
                <p>Participants will include primary caregivers of children post HCT. Primary caregivers will be identified by study staff through NCH’s HCT unit electronic medical record prior to the child’s discharge. Children of caregivers must be: (a) 0 to 21 years of age, (b) receiving immunosuppression for an allogenic transplant, (c) discharged prior to day 100 or immunosuppression taper, and (d) residing with a primary caregiver that enrolls on the study. Primary caregivers must be: (a) English-speaking and (b) have an iOS or Android capable cellular device. To be inclusive of varying family structures, eligible primary caregivers may also include any legal guardian of the child (e.g., adoptive parent, grandparent, aunt/uncle, etc.). Caregivers are ineligible if they are unable to consent or the participating child has a documented developmental delay.</p>
              </sec>
              <sec id="sec006">
                <title>Sample size calculations</title>
                <p>The overall goal of this pilot RCT is to examine preliminary acceptability and efficacy of the BMT4me© app and assess the feasibility of enrolling and retaining 50 caregivers of children in the acute phase post-HCT. The sample of 50 caregivers (25 intervention, 25 standard of care) was chosen to inform a multi-site, confirmatory RCT that will be sufficiently powered. Estimates of potential recruitment/retention rates are based on cancer registry data and high recruitment rates at NCH for this population of caregivers. Estimated rates of recruitment are feasible considering there are approximately 80 HCT completed annually at NCH. Thus, there will be an ample number of eligible families to approach. We will compute effect sizes (e.g., standardized mean difference) using two-sided Type I error rates of α &lt; .05 for the randomized group comparison to use for our future work assessing the efficacy of the intervention.</p>
              </sec>
              <sec id="sec007">
                <title>Recruitment and randomization</title>
                <p>Primary caregivers of children post-HCT will be approached in person after engraftment occurs and prior to the child’s discharge. If families express interest in participating, trained research staff will explain the purpose of the study and the study activities. Upon receiving confirmation from caregivers that they would like to participate, research staff will then guide them through the informed consent process (either written or electronic, whichever they prefer).</p>
                <p>After informed consent is obtained, primary caregivers will be randomized to either the control (standard of care) group or the intervention (BMT4me© app) group. Randomization will be created in the online data collection tool REDCap<sup>®</sup> [<xref rid="pone.0289987.ref035" ref-type="bibr">35</xref>] by the project’s statistician via a Randomization Module. The randomization sequence will be based on a design with blocks of four or six, chosen randomly within the sequence with equal probability. Randomly varying block sizes reduce the chance that research staff will guess the next group assignment, minimizing unconscious bias. The randomization sequence is protected and only the statistician will be able to edit it. However, study staff will have permissions to randomize and see the allocated group assignments when they log into REDCap<sup><bold><italic toggle="yes">®</italic></bold></sup>.</p>
                <p>Following randomization, caregivers will be asked to complete baseline assessments <bold>(<xref rid="pone.0289987.t001" ref-type="table">Table 1</xref></bold>). All families will receive standard education at discharge with regards to medications and a medication list for their child. An electronic adherence monitoring device will be administered to all families at the beginning of the study. Caregivers of children prescribed immunosuppressant medications in a liquid form will receive a Medy remote patient management (MedyRPM) box [<xref rid="pone.0289987.ref036" ref-type="bibr">36</xref>]. MedyRPM will collect adherence data each time the box lid is opened and closed via a Bluetooth HUB and enabled monitor attached to the box [<xref rid="pone.0289987.ref036" ref-type="bibr">36</xref>]. Data will be transmitted via LTE connectivity cloud services and be available for viewing by study staff on a comprehensive patient management portal [<xref rid="pone.0289987.ref036" ref-type="bibr">36</xref>]. Caregivers of children who are receiving their immunosuppressant medication via pill or capsule will have the option of either using a MedyRPM box or medication event monitoring system<italic toggle="yes">®</italic> (MEMS) cap [<xref rid="pone.0289987.ref037" ref-type="bibr">37</xref>], whichever they prefer, for the duration of the study. MEMS<italic toggle="yes">®</italic> Caps have been used consistently to measure medication adherence [<xref rid="pone.0289987.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0289987.ref039" ref-type="bibr">39</xref>] by collecting data via a micro-electronic circuit which date/timestamps when the container is opened and closed. Study staff will download the data collected on the MEMS<italic toggle="yes">®</italic> cap weekly via the MEMS<italic toggle="yes">®</italic> adherence desktop software [<xref rid="pone.0289987.ref037" ref-type="bibr">37</xref>]. Additionally, caregivers assigned to the intervention group will have the BMT4me© app downloaded onto their personal device to log doses of medications. Brief follow-up assessments will occur weekly in person during participants’ clinical appointments or virtually, via email or telephone, whichever the family prefers, in both groups. Reasons for non-participation and dropout will be tracked. Each family will be given a $50 gift card at their time of enrollment, followed by another $25 at the end of the study, for a total of $75 in subject compensation. See <bold><xref rid="pone.0289987.g001" ref-type="fig">Fig 1</xref></bold> for a timeline of the study.</p>
                <fig position="float" id="pone.0289987.g001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0289987.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>BMT4me app screenshots.</title>
                  </caption>
                  <graphic xlink:href="pone.0289987.g001" position="float"/>
                </fig>
                <table-wrap position="float" id="pone.0289987.t001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0289987.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Measure descriptions by visit.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0289987.t001" id="pone.0289987.t001g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">Visit</th>
                          <th align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">Activity </th>
                          <th align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">Description </th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>Enrollment</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Randomization </italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Families will be randomized into one of two groups immediately following consent. If they are assigned to the intervention group, they will receive the mHealth app for medication tracking. If they are assigned to the control group, they will not receive the mHealth app. </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Demographic Questionnaire </italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Research staff ask participants to answer questions about age, race, ethnicity, religion, educational attainment, income (parents only), whom they live with, and their relationship to their child (parents only). </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>Enrollment and Exit</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Posttransplant Perception Survey</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">A 4-item self-report clinical assessment tool asking participants to report on their views about their child’s health and perceptions post-transplant. Items are rated on a 5-point Likert scale. Administered at enrollment and exit of the study.</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Barrier Scale </italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">A self-report clinical assessment tool with 14 commonly endorsed barriers. Domains include logistical issues (e.g., forgetting, inconvenience), ingestion difficulties (e.g., swallowing, taste), efficacy (e.g., feel I don’t need it), financial difficulties, regimen characteristics (e.g., too many medications, side effects), and patient-specific issues (e.g., refusal by child, embarrassment). Administered at enrollment and exit of the study. </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="4" colspan="1">
                            <bold>Weekly</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Medication Adherence Measure (MAM) </italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">The MAM is semi-structured interview specific to pediatrics, conducted with the parent weekly, to obtain an individual score in each module. The score is represented in percentages of the number of required doses. A total summary score can be calculated across all medications, as well as separately.</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Readmissions </italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">Readmission rates will be determined by the number of admissions requiring greater than a 24-hour stay within the first 100 days after discharge. Reason for readmission will be recorded and based on the EMR discharge diagnosis. Data will be collected weekly.</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic toggle="yes">Graft vs</italic>. <italic toggle="yes">Host Disease (GVHD) </italic></td>
                          <td align="justify" rowspan="1" colspan="1">GVHD will be assessed on the international standard acute GVHD grading and staging scale.55 Provider grading will be per organ system on a 1–4 scale, with an overall score collected weekly. </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Immunosuppressant assay levels</italic>
                          </td>
                          <td align="justify" rowspan="1" colspan="1">Immunosuppressant serum assays are collected weekly during the acute phase. A calculation of the degree of variation among the levels collected will be formulated to assess adherence to the prescribed immunosuppressant medication. </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>3-Week Intervals</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Pediatric Quality of Life Inventory (PedsQL) </italic>
                          </td>
                          <td align="justify" rowspan="1" colspan="1">Parents will complete the Pediatric Quality of Life Inventory (PedsQL) every three weeks (at week 3, week 6, and week 9). The frequency of 23 problems in 4 domains (i.e., physical, emotional, social, school) are rated on a 3 or 5-point scale. Versions are based on child age: (a) 1–12, (b) 13–24 months old and (c) 2–4, (d) 5–7, (b) 8–12 and, (c) 13–18 years old. </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" colspan="1">
                            <bold>Monthly</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Medy Remote Patient Management (RPM) medication box </italic>
                          </td>
                          <td align="justify" rowspan="1" colspan="1">Medy RPM collects daily date and time-stamped data via an NFC reader. Each opening and closing is assumed to reflect an administered and consumed medication dose. This data will be collected monthly from participants as a direct measure of adherence.</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">MEMS Cap </italic>
                          </td>
                          <td align="justify" rowspan="1" colspan="1">MEMS Caps collect daily date and time stamped data via a micro-electronic circuit that registers the opening and closing of the threaded pill bottle. Each opening and closing is assumed to reflect an administered and consumed medication dose. This data will be collected monthly from participants as a direct measure of adherence.</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Exit</bold>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">Caregiver Satisfaction</italic>
                          </td>
                          <td align="justify" rowspan="1" colspan="1">For the intervention group only, satisfaction will be assessed at the end of the study via semi-structured interviews and electronic surveys. Caregivers will be asked for feedback regarding participation in the intervention, benefit, burden, barriers, suggested modifications, and overall satisfaction. Suggested modifications to the app and advice to the healthcare team will also be solicited. </td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec008">
                <title>Intervention</title>
                <p>The BMT4me© app intervention was informed by Behavioral Economics (BE) Theory [<xref rid="pone.0289987.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0289987.ref041" ref-type="bibr">41</xref>] and the Pediatric Self-management Model [<xref rid="pone.0289987.ref042" ref-type="bibr">42</xref>]. Stakeholder feedback of wireframes was conducted through a mixed methods usability study and informed the initial development of the app. Then, the intervention was tested in a pilot study of primary caregivers of children discharged after HCT in a quasi-experimental pre-post design [<xref rid="pone.0289987.ref043" ref-type="bibr">43</xref>]. Caregiver feedback during final qualitative interviews were utilized to further modify the app, resulting in the current intervention (BMT4me 2.0©) employed within the scope of this RCT.</p>
                <p>BMT4me 2.0© (<bold><xref rid="pone.0289987.g002" ref-type="fig">Fig 2</xref></bold>) was designed to aid in the management of medications, improve adherence monitoring, and track symptoms or medication side effects in real-time [<xref rid="pone.0289987.ref043" ref-type="bibr">43</xref>]. The app’s push notification feature reminds users of medication doses, utilizes ecological momentary assessment (EMA) [<xref rid="pone.0289987.ref044" ref-type="bibr">44</xref>] to record the time a medication was taken, and prompts users to provide reasons for missed doses. Users can add medications by entering them directly into the app or by capturing an image of the prescription with their phone camera with the image-to-text feature. Additionally, users can record symptoms and severity on a 1-to-10 sliding scale, with corresponding changing emojis. These visual aids make symptom entry more convenient and easily understandable for app users. Other features include a notes page for recording details of care, as well as the ability to upload photos and weekly summaries that can be converted to pdf format and shared with providers. The app is available for download on both iOS and Android devices in English language.</p>
                <fig position="float" id="pone.0289987.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0289987.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Schedule of enrollment, interventions, and assessments.</title>
                  </caption>
                  <graphic xlink:href="pone.0289987.g002" position="float"/>
                </fig>
                <p>After randomization, caregivers randomized to the BMT4me<italic toggle="yes">©</italic> app will have the application installed on their personal cell phone device prior to discharge at no cost. Research staff will conduct a brief tutorial on functions and demonstrate use. These sessions will be audio-recorded (treatment fidelity). The caregiver will add immunosuppressants and the schedule for administration with oversight by the primary discharge nurse to ensure accuracy. Accuracy of medications within the app will be verified and recorded at each study visit, conducted during the child’s weekly clinic appointment (fidelity check). Caregivers will receive a reminder when their child’s immunosuppressant medication is due based on their chosen medication administration schedule.</p>
              </sec>
              <sec id="sec009">
                <title>Data collection</title>
                <p>Data will be collected at the following time points from both groups; discharge, weekly for the first 100 days (i.e., approximately 11 weeks) post-discharge, or until the participant’s child completes their taper from immunosuppressant medication, and monthly (for approximately 3 months). Specifically, the following data will be collected: baseline medical information (i.e., diagnosis, age at diagnosis, treatment history, medications), demographic characteristics, perceptions post-HCT, barriers to medication adherence, serum immunosuppression assays, caregiver reports of adherence to medications, and caregiver proxy report of child quality of life. Monthly electronic adherence monitoring devices and clinical outcomes data will also be collected in both groups. At the conclusion of the study, caregivers in the intervention group will complete the System Usability Scale. Caregivers in both groups will participate in a 15–30 minute semi-structured interview addressing: 1) experience with adherence post-transplant and participation in the trial (e.g., benefit, burden, barriers, satisfaction) and 2) caregivers in the app arm will be asked to share any suggestions to improve the BMT4me<italic toggle="yes">©</italic> app. Measures are described in <bold><xref rid="pone.0289987.t001" ref-type="table">Table 1</xref></bold>.</p>
              </sec>
              <sec id="sec010">
                <title>Outcomes</title>
                <p>The primary expected outcome of this study is that caregivers will report above average acceptability (≥ 68%) of the BMT4me<italic toggle="yes">©</italic> app and those families randomized to receive the BMT4me<italic toggle="yes">©</italic> app will have higher medication adherence frequency than the standard of care group. The secondary expected outcome is that those children whose caregiver was randomized to receive the BMT4me<italic toggle="yes">©</italic> app will have less GVHD and fewer readmissions compared to the standard of care group. Descriptive statistics, correlations, and independent samples t-tests will examine the primary and secondary outcomes. The goal of this intervention is to increase adherence to immunosuppressant medication and improve key clinical outcomes such as graft vs. host disease and readmissions relative to standard care.</p>
              </sec>
              <sec id="sec011">
                <title>Ethics</title>
                <p>The Institutional Review Board (IRB) at NCH approved the project (#STUDY00002478) on March 22, 2022. Eligible participants include caregivers aged 18 or older. All eligible participants will provide written informed consent via pen and paper or electronically through an electronic signature module on REDCap [<xref rid="pone.0289987.ref035" ref-type="bibr">35</xref>] prior to study participation. This trial is registered in ClinicalTrials.gov (identifier NCT05515497). At the conclusion of the study, data will be made available and results from the trial will be submitted to ClinicalTrials.gov.</p>
                <p>Due to the sensitive nature of the project, staff members have and will continue completing extensive training in research ethics both internally through NCH’s Learning Center modules and externally through the Collaborative Institutional Training Initiative (CITI) [<xref rid="pone.0289987.ref045" ref-type="bibr">45</xref>] online training portal. Moreover, staff will be closely supervised by the primary investigator (PI) who has extensive experience working with families and children undergoing HCT. The only authors of this manuscript who have access to information that could identify individual participants prior to, during, or after data collection are members of the research team who have received approval from the IRB at NCH.</p>
              </sec>
            </sec>
            <sec id="sec012">
              <title>Statistical analyses</title>
              <sec id="sec013">
                <title>Quantitative</title>
                <p>During the passive use observation period, passive data modules will capture phone activity and caregivers’ application use (e.g., time/date, duration of use). Descriptive statistics will be used to analyze phone activity. Correlations will be used to investigate app use behavior over time. Acceptability will be assessed by averaging total scores from the system usability scale (SUS). Consistent with the literature [<xref rid="pone.0289987.ref046" ref-type="bibr">46</xref>–<xref rid="pone.0289987.ref048" ref-type="bibr">48</xref>], scores greater than 68% on the SUS will be considered acceptable [<xref rid="pone.0289987.ref049" ref-type="bibr">49</xref>]. The proportion of participants that enroll and complete the study will be examined to assess study feasibility.</p>
                <p>The potential efficacy of the BMT4me© app will be examined using an independent samples t-test where the outcome is the proportion of adherence (i.e., the number of doses taken divided by the number of doses prescribed). If adherence is substantially non-normal, efficacy will be examined using an analogous logistic regression model. GVHD stages will be compared between the intervention and usual care groups using a chi-square analysis given the ordinal nature of this variable, whereas number of readmissions will be compared across the two groups using an independent samples t-test. If the number of readmissions is substantially non-normal, an analogous Poisson regression model will be used. Because the nature of the study is exploratory rather than confirmatory, the objective of the analysis is effect size estimation rather than formal hypothesis testing, and threats to power (e.g., participant attrition due to patient death, early taper) are not a primary concern. We will compute effect sizes (e.g., a standardized mean difference) for the randomized group comparison to inform our future work assessing the efficacy of the intervention on adherence to immunosuppression medication. Moreover, an exploratory aim will examine moderators by adding an interaction term and corresponding main effect for the moderator to the statistical model via the statistical software Mplus.</p>
              </sec>
              <sec id="sec014">
                <title>Qualitative</title>
                <p>Interviews will be audio-taped and transcribed verbatim then imported into NVivo [<xref rid="pone.0289987.ref050" ref-type="bibr">50</xref>]. The qualitative data analysis computer software within NVivo will then be utilized for content analysis using the constant comparison method, by at least two independent, trained, doctoral level coders. Study staff will read with immersion (i.e., repeatedly reading a subset of transcripts), cluster similar ideas to inform preliminary categories, and review and revise coding schemes. Study staff will then apply the codes to a second subset of transcripts, revise them as necessary, and repeat this process until saturation is reached [<xref rid="pone.0289987.ref051" ref-type="bibr">51</xref>–<xref rid="pone.0289987.ref053" ref-type="bibr">53</xref>]. Member checking will be completed with a subsample to obtain family input on thematic codes as a final validity check. Frequency counts of final themes will be obtained [<xref rid="pone.0289987.ref052" ref-type="bibr">52</xref>].</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec015">
              <title>Discussion</title>
              <p>While long-term survival rates and better clinical outcomes have increased in pediatric hematological and oncological populations due to innovative therapies, poor adherence persists [<xref rid="pone.0289987.ref054" ref-type="bibr">54</xref>]. Reasons for non-adherence are complex, but may be due to levels of caregiver engagement, age of child, social factors, and cognitive factors [<xref rid="pone.0289987.ref055" ref-type="bibr">55</xref>]. Thus, with nearly 2,500 children receiving HCT annually [<xref rid="pone.0289987.ref056" ref-type="bibr">56</xref>]- and the increased societal burden (e.g., increases in costs of care and need for more clinicians to care for children due to the occurrence of adverse outcomes as they relate to non-adherence) associated with the higher number of transplants each year [<xref rid="pone.0289987.ref057" ref-type="bibr">57</xref>–<xref rid="pone.0289987.ref059" ref-type="bibr">59</xref>] there is a need for research examining potential targeted interventions to address non-adherence to medication regimens. The strengths of this RCT and digital health intervention include constructs from behavioral health and BE theory, which drive data collection and analysis [<xref rid="pone.0289987.ref043" ref-type="bibr">43</xref>], as well as the use of a mixed methods approach, which will allow for a comprehensive understanding of the acceptability and efficacy of the BMT4me<italic toggle="yes">©</italic> app intervention and the feasibility of enrolling 50 caregivers of children discharged following HCT. Additionally, the intervention has undergone numerous rounds of testing with families and stakeholders (i.e., HCT families, physicians, and nurses) whose unique and vital perspectives have informed its development to make it more desirable to HCT families. Finally, the universally accessible nature of the intervention means that families’ sociodemographic factors (e.g., distance from hospital/treatment site, access to reliable transportation and Wi-Fi, affordability of the intervention, etc.), which have been reported as barriers in the implementation of other interventions [<xref rid="pone.0289987.ref060" ref-type="bibr">60</xref>, <xref rid="pone.0289987.ref061" ref-type="bibr">61</xref>], are not applicable within the context of this study.</p>
              <p>This study design is not without potential limitations. First, participation may be burdensome; however, assessments are purposefully brief to reduce burden and caregivers will have the option of completing paper/pencil or electronic measures. Participants may also complete measures virtually via REDCap link or over the phone with study staff so their weekly clinic appointments are not impeded. Although some families may not have smartphones, we do not expect access to technology will be a significant exclusionary factor, as &gt;90% of adults in the US own a mobile device [<xref rid="pone.0289987.ref062" ref-type="bibr">62</xref>]. If access is a problem, smartphones will be provided to families. Finally, the intervention is only available to English-speaking caregivers at this time, but opportunities to expand the intervention’s inclusivity (i.e., adding additional languages) are being pursued.</p>
            </sec>
            <sec sec-type="conclusions" id="sec016">
              <title>Conclusion</title>
              <p>In this protocol, we describe an RCT to evaluate the acceptability and efficacy of the newly developed BMT4me<italic toggle="yes">©</italic> app, as well as the feasibility of recruiting and retaining 50 caregivers of children who have been discharged during the acute phase post-HCT. Based on behavioral economics theories and adherence literature, we predict that this novel intervention will assist families in managing post-discharge medications, increase their adherence to medical regimens, and mitigate the onset of GVHD and subsequent readmissions. It is our understanding that this is the first prospective, longitudinal RCT examining the effects of the BMT4me<italic toggle="yes">©</italic> smartphone application intervention on adherence to immunosuppressant medications in the pediatric HCT population. Ensuing outcomes will address critical gaps in non-adherence knowledge and inform future studies of digital intervention outcomes in pediatric HCT.</p>
            </sec>
            <sec id="sec017" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0289987.s001" position="float" content-type="local-data">
                <label>S1 File</label>
                <caption>
                  <title>SPIRIT checklist.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0289987.s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0289987.s002" position="float" content-type="local-data">
                <label>S2 File</label>
                <caption>
                  <title>Study protocol.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0289987.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0289987.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Bissonnette</surname><given-names>JM</given-names></name>. <article-title>Adherence: a concept analysis.</article-title><source>J Adv Nurs.</source><year>2008</year><month>Sep</month>;<volume>63</volume>(<issue>6</issue>):<fpage>634</fpage>–<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2648.2008.04745.x</pub-id>
<?supplied-pmid 18808585?><pub-id pub-id-type="pmid">18808585</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>McGrady</surname><given-names>ME</given-names></name>, <name><surname>Hommel</surname><given-names>KA</given-names></name>. <article-title>Medication adherence and health care utilization in pediatric chronic illness: a systematic review</article-title>. <source>Pediatrics</source>. <year>2013</year><month>Oct</month>;<volume>132</volume>(<issue>4</issue>):<fpage>730</fpage>–<lpage>40</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1542/peds.2013-1451</pub-id>
<?supplied-pmid 23999953?><pub-id pub-id-type="pmid">23999953</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Drotar</surname><given-names>D</given-names></name>, <name><surname>Crawford</surname><given-names>P</given-names></name>, <name><surname>Bonner</surname><given-names>M</given-names></name>. <article-title>Collaborative decision-making and promoting treatment adherence in pediatric chronic illness.</article-title><source>Patient Intelligence</source>. <year>2010</year>;<volume>2</volume>:<fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Drotar</surname><given-names>D.</given-names></name><article-title>Strategies of adherence promotion in the management of pediatric chronic conditions.</article-title><source>J Dev Behav Pediatr.</source><year>2013</year><month>Nov</month>;<volume>34</volume>(<issue>9</issue>):<fpage>716</fpage>–<lpage>29</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/DBP.0b013e31829f6781</pub-id>
<?supplied-pmid 24247913?><pub-id pub-id-type="pmid">24247913</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Fiese</surname><given-names>B.</given-names></name><article-title>Medical Adherence and Childhood Chronic Illness: family daily management skills and emotional climate as emerging contributors Current Opinions in</article-title>. <source>Pediatrics</source>. <year>2006</year>;<volume>8</volume>:<fpage>551</fpage>–<lpage>7</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Landier</surname><given-names>W.</given-names></name><article-title>Age span challenges: adherence in pediatric oncology</article-title>. <source>Semin Oncol Nurs</source>. <year>2011</year><month>May</month>;<volume>27</volume>(<issue>2</issue>):<fpage>142</fpage>–<lpage>53</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.soncn.2011.02.006</pub-id>
<?supplied-pmid 21514483?><pub-id pub-id-type="pmid">21514483</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Ice</surname><given-names>LL</given-names></name>, <name><surname>Bartoo</surname><given-names>GT</given-names></name>, <name><surname>McCullough</surname><given-names>KB</given-names></name>, <name><surname>Wolf</surname><given-names>RC</given-names></name>, <name><surname>Dierkhising</surname><given-names>RA</given-names></name>, <name><surname>Mara</surname><given-names>KC</given-names></name>, <etal>et al</etal>. <article-title>A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation Patients.</article-title><source>Biol Blood Marrow Transplant</source>. <year>2020</year><month>Sep</month>;<volume>26</volume>(<issue>9</issue>):<fpage>1627</fpage>–<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bbmt.2020.05.020</pub-id>
<?supplied-pmid 32505809?><pub-id pub-id-type="pmid">32505809</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Posluszny</surname><given-names>DM</given-names></name>, <name><surname>Bovbjerg</surname><given-names>DH</given-names></name>, <name><surname>Syrjala</surname><given-names>KL</given-names></name>, <name><surname>Agha</surname><given-names>M</given-names></name>, <name><surname>Farah</surname><given-names>R</given-names></name>, <name><surname>Hou</surname><given-names>JZ</given-names></name>, <etal>et al</etal>. <article-title>Rates and predictors of nonadherence to the post-allogeneic hematopoietic cell transplantation medical regimen in patients and caregivers</article-title>. <source>Transplant Cell Ther</source>. <year>2022</year><month>Mar</month>;<volume>28</volume>(<issue>3</issue>):<fpage>165.e1</fpage>–<lpage>165.e9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jtct.2021.11.020</pub-id>
<?supplied-pmid 34875403?><pub-id pub-id-type="pmid">34875403</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Pai</surname><given-names>ALH</given-names></name>, <name><surname>McGrady</surname><given-names>M</given-names></name>. <article-title>Systematic review and meta-analysis of psychological interventions to promote treatment adherence in children, adolescents, and young adults with chronic illness</article-title>. <source>J Pediatr Psychol</source>. <year>2014</year><month>Sep</month>;<volume>39</volume>(<issue>8</issue>):<fpage>918</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jpepsy/jsu038</pub-id>
<?supplied-pmid 24952359?><pub-id pub-id-type="pmid">24952359</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Pai</surname><given-names>ALH</given-names></name>, <name><surname>Rausch</surname><given-names>J</given-names></name>, <name><surname>Drake</surname><given-names>S</given-names></name>, <name><surname>Morrison</surname><given-names>CF</given-names></name>, <name><surname>Lee</surname><given-names>JL</given-names></name>, <name><surname>Nelson</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Poor adherence is associated with more infections after pediatric hematopoietic stem cell transplant</article-title>. <source>Biol Blood Marrow Transplant</source>. <year>2018</year><month>Feb</month>;<volume>24</volume>(<issue>2</issue>):<fpage>381</fpage>–<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bbmt.2017.10.033</pub-id>
<?supplied-pmid 29102720?><pub-id pub-id-type="pmid">29102720</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Quine</surname><given-names>L</given-names></name>, <name><surname>Steadman</surname><given-names>L</given-names></name>, <name><surname>Thompson</surname><given-names>S</given-names></name>, <name><surname>Rutter</surname><given-names>DR</given-names></name>. <article-title>Adherence to anti-hypertensive medication: proposing and testing a conceptual model.</article-title><source>Br J Health Psychol.</source><year>2012</year><month>Feb</month>;<volume>17</volume>(<issue>1</issue>):<fpage>202</fpage>–<lpage>19</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.2044-8287.2011.02034.x</pub-id>
<?supplied-pmid 22107150?><pub-id pub-id-type="pmid">22107150</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Skeens</surname><given-names>M</given-names></name>, <name><surname>Akard</surname><given-names>TF</given-names></name>, <name><surname>Gilmer</surname><given-names>MJ</given-names></name>, <name><surname>Garee</surname><given-names>A</given-names></name>, <name><surname>Miller</surname><given-names>A</given-names></name>. <article-title>Toward a better understanding of pediatric BMT adherence: An exploration of provider perceptions.</article-title><source>Biol Blood Marrow Transplant</source>. <year>2014</year><month>Feb</month>;<volume>20</volume>(<issue>2</issue>):<fpage>S315</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Saad</surname><given-names>A</given-names></name>, <name><surname>de Lima</surname><given-names>M</given-names></name>, <name><surname>Anand</surname><given-names>S</given-names></name>, <name><surname>Bhatt</surname><given-names>VR</given-names></name>, <name><surname>Bookout</surname><given-names>R</given-names></name>, <name><surname>Chen</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Hematopoietic Cell Transplantation, version 2.2020, NCCN clinical practice Guidelines in oncology.</article-title><source>J Natl Compr Canc Netw.</source><year>2020</year><month>May</month><day>1</day>;<volume>18</volume>(<issue>5</issue>):<fpage>599</fpage>–<lpage>634</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.6004/jnccn.2020.0021</pub-id>
<?supplied-pmid 32519831?><pub-id pub-id-type="pmid">32519831</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Skeens</surname><given-names>MA</given-names></name>, <name><surname>Dietrich</surname><given-names>MS</given-names></name>, <name><surname>Ryan-Wenger</surname><given-names>N</given-names></name>, <name><surname>Gilmer</surname><given-names>MJ</given-names></name>, <name><surname>Mulvaney</surname><given-names>SA</given-names></name>, <name><surname>Akard</surname><given-names>TF</given-names></name>. <article-title>The Medication Level Variability Index (MLVI) as a potential predictive biomarker of graft-versus-host disease in pediatric hematopoietic stem cell transplant patients.</article-title><source>Pediatr Transplant</source>. <year>2019</year><month>Aug</month>;<volume>23</volume>(<issue>5</issue>):<fpage>e13451</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/petr.13451</pub-id><?supplied-pmid 31066981?><pub-id pub-id-type="pmid">31066981</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Gresch</surname><given-names>B</given-names></name>, <name><surname>Kirsch</surname><given-names>M</given-names></name>, <name><surname>Fierz</surname><given-names>K</given-names></name>, <name><surname>Halter</surname><given-names>JP</given-names></name>, <name><surname>Nair</surname><given-names>G</given-names></name>, <name><surname>Denhaerynck</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study.</article-title><source>Bone Marrow Transplant</source>. <year>2017</year><month>Feb</month>;<volume>52</volume>(<issue>2</issue>):<fpage>304</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/bmt.2016.262</pub-id>
<?supplied-pmid 27841860?><pub-id pub-id-type="pmid">27841860</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Phan</surname><given-names>M</given-names></name>, <name><surname>Chavan</surname><given-names>R</given-names></name>, <name><surname>Beuttler</surname><given-names>R</given-names></name>, <name><surname>Benipayo</surname><given-names>N</given-names></name>, <name><surname>Magedman</surname><given-names>G</given-names></name>, <name><surname>Buchbinder</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Evaluating risk factors for acute graft versus host disease in pediatric hematopoietic stem cell transplant patients receiving tacrolimus</article-title>. <source>Clin Transl Sci</source>. <year>2021</year><month>Jul</month>;<volume>14</volume>(<issue>4</issue>):<fpage>1303</fpage>–<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/cts.12982</pub-id>
<?supplied-pmid 33503293?><pub-id pub-id-type="pmid">33503293</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Wolff</surname><given-names>D</given-names></name>, <name><surname>Lawitschka</surname><given-names>A</given-names></name>. <article-title>Chronic graft-versus-host disease</article-title>. <source>The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies</source>. <year>2019</year>;<fpage>331</fpage>–<lpage>45</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Shemesh</surname><given-names>E</given-names></name>, <name><surname>Shneider</surname><given-names>BL</given-names></name>, <name><surname>Savitzky</surname><given-names>JK</given-names></name>, <name><surname>Arnott</surname><given-names>L</given-names></name>, <name><surname>Gondolesi</surname><given-names>GE</given-names></name>, <name><surname>Krieger</surname><given-names>NR</given-names></name>, <etal>et al</etal>. <article-title>Medication adherence in pediatric and adolescent liver transplant recipients</article-title>. <source>Pediatrics</source>. <year>2004</year><month>Apr</month>;<volume>113</volume>(<issue>4</issue>):<fpage>825</fpage>–<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1542/peds.113.4.825</pub-id>
<?supplied-pmid 15060234?><pub-id pub-id-type="pmid">15060234</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Varni</surname><given-names>JW</given-names></name>, <name><surname>Wallander</surname><given-names>JL</given-names></name>. <article-title>Adherence to health-related regimens in pediatric chronic disorders.</article-title><source>Clin Psychol Rev.</source><year>1984</year><month>Jan</month>;<volume>4</volume>(<issue>5</issue>):<fpage>585</fpage>–<lpage>96</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Phipps</surname><given-names>S</given-names></name>, <name><surname>DeCuir-Whalley</surname><given-names>S</given-names></name>. <article-title>Adherence issues in pediatric bone marrow transplantation</article-title>. <source>J Pediatr Psychol</source>. <year>1990</year><month>Aug</month>;<volume>15</volume>(<issue>4</issue>):<fpage>459</fpage>–<lpage>75</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jpepsy/15.4.459</pub-id>
<?supplied-pmid 2258795?><pub-id pub-id-type="pmid">2258795</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Hommel</surname><given-names>KA</given-names></name>, <name><surname>Ramsey</surname><given-names>RR</given-names></name>, <name><surname>Rich</surname><given-names>KL</given-names></name>, <name><surname>Ryan</surname><given-names>JL</given-names></name>. <article-title>Adherence to pediatric treatment regimens.</article-title><source>Handbook of pediatric psychology.</source><year>2017</year>;<volume>5</volume>:<fpage>119</fpage>–<lpage>33</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Plevinsky</surname><given-names>JM</given-names></name>, <name><surname>Gutierrez-Colina</surname><given-names>AM</given-names></name>, <name><surname>Carmody</surname><given-names>JK</given-names></name>, <name><surname>Hommel</surname><given-names>KA</given-names></name>, <name><surname>Crosby</surname><given-names>LE</given-names></name>, <name><surname>McGrady</surname><given-names>ME</given-names></name>, <etal>et al</etal>. <article-title>Patient-reported outcomes for pediatric adherence and self-management: A systematic review</article-title>. <source>J Pediatr Psychol</source>. <year>2020</year><month>Apr</month><day>1</day>;<volume>45</volume>(<issue>3</issue>):<fpage>340</fpage>–<lpage>57</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jpepsy/jsz096</pub-id>
<?supplied-pmid 31845997?><pub-id pub-id-type="pmid">31845997</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Hoegy</surname><given-names>D</given-names></name>, <name><surname>Bleyzac</surname><given-names>N</given-names></name>, <name><surname>Rochet</surname><given-names>C</given-names></name>, <name><surname>De Freminville</surname><given-names>H</given-names></name>, <name><surname>Rénard</surname><given-names>C</given-names></name>, <name><surname>Kébaili</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Medication adherence after pediatric allogeneic stem cell transplantation: Barriers and facilitators.</article-title><source>Eur J Oncol Nurs</source>. <year>2019</year><month>Feb</month>;<volume>38</volume>:<fpage>1</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ejon.2018.11.006</pub-id>
<?supplied-pmid 30717930?><pub-id pub-id-type="pmid">30717930</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Laghari</surname><given-names>M</given-names></name>, <name><surname>Talpur</surname><given-names>BA</given-names></name>, <name><surname>Sulaiman</surname><given-names>SAS</given-names></name>, <name><surname>Khan</surname><given-names>AH</given-names></name>, <name><surname>Bhatti</surname><given-names>Z</given-names></name>. <article-title>Assessment of adherence to anti-tuberculosis treatment and predictors for non-adherence among the caregivers of children with tuberculosis</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>2021</year><month>Aug</month><day>2</day>;<volume>115</volume>(<issue>8</issue>):<fpage>904</fpage>–<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/trstmh/traa161</pub-id>
<?supplied-pmid 33382889?><pub-id pub-id-type="pmid">33382889</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Santer</surname><given-names>M</given-names></name>, <name><surname>Ring</surname><given-names>N</given-names></name>, <name><surname>Yardley</surname><given-names>L</given-names></name>, <name><surname>Geraghty</surname><given-names>AWA</given-names></name>, <name><surname>Wyke</surname><given-names>S</given-names></name>. <article-title>Treatment non-adherence in pediatric long-term medical conditions: systematic review and synthesis of qualitative studies of caregivers’ views</article-title>. <source>BMC Pediatr</source>. <year>2014</year><month>Mar</month><day>4</day>;<volume>14</volume>:<fpage>63</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2431-14-63</pub-id><?supplied-pmid 24593304?><pub-id pub-id-type="pmid">24593304</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Douthit</surname><given-names>N</given-names></name>, <name><surname>Kiv</surname><given-names>S</given-names></name>, <name><surname>Dwolatzky</surname><given-names>T</given-names></name>, <name><surname>Biswas</surname><given-names>S</given-names></name>. <article-title>Exposing some important barriers to health care access in the rural USA.</article-title><source>Public Health.</source><year>2015</year><month>Jun</month>;<volume>129</volume>(<issue>6</issue>):<fpage>611</fpage>–<lpage>20</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.puhe.2015.04.001</pub-id>
<?supplied-pmid 26025176?><pub-id pub-id-type="pmid">26025176</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>García-Sánchez</surname><given-names>S</given-names></name>, <name><surname>Somoza-Fernández</surname><given-names>B</given-names></name>, <name><surname>de Lorenzo-Pinto</surname><given-names>A</given-names></name>, <name><surname>Ortega-Navarro</surname><given-names>C</given-names></name>, <name><surname>Herranz-Alonso</surname><given-names>A</given-names></name>, <name><surname>Sanjurjo</surname><given-names>M</given-names></name>. <article-title>Mobile health apps providing information on drugs for adult emergency care: Systematic search on app stores and content analysis.</article-title><source>JMIR MHealth UHealth.</source><year>2022</year><month>Apr</month><day>20</day>;<volume>10</volume>(<issue>4</issue>):<fpage>e29985</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/29985</pub-id><?supplied-pmid 35442212?><pub-id pub-id-type="pmid">35442212</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Hommel</surname><given-names>KA</given-names></name>, <name><surname>Gray</surname><given-names>WN</given-names></name>, <name><surname>Hente</surname><given-names>E</given-names></name>, <name><surname>Loreaux</surname><given-names>K</given-names></name>, <name><surname>Ittenbach</surname><given-names>RF</given-names></name>, <name><surname>Maddux</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology.</article-title><source>Contemp Clin Trials.</source><year>2015</year><month>Jul</month>;<volume>43</volume>:<fpage>105</fpage>–<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cct.2015.05.013</pub-id>
<?supplied-pmid 26003436?><pub-id pub-id-type="pmid">26003436</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref029">
                <label>29</label>
                <mixed-citation publication-type="book"><collab>IQVIA Institute For Human Data Science</collab>. <source>Digital Health Trends 2021: Innovation, Evidence, Regulation, and Adoption [Internet].</source><publisher-name>IQVIA</publisher-name>. <year>2023</year> [cited 2023 Apr 20]. Available from: <ext-link xlink:href="https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/digital-health-trends-2021/iqvia-institute-digital-health-trends-2021.pdf?&amp;_=1652464150373" ext-link-type="uri">https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/digital-health-trends-2021/iqvia-institute-digital-health-trends-2021.pdf?&amp;_=1652464150373</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref030">
                <label>30</label>
                <mixed-citation publication-type="book"><collab>Statista</collab>. <part-title>Number of mHealth apps available in the Google Play Store from 1st quarter 2015 to 2nd quarter of 2022 [Internet]</part-title>. <publisher-name>Statista</publisher-name>. <year>2023</year> [cited 2022 Sep 15]. Available from: <ext-link xlink:href="https://www.statista.com/statistics/779919/health-apps-available-google-play-worldwide/" ext-link-type="uri">https://www.statista.com/statistics/779919/health-apps-available-google-play-worldwide/</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Fedele</surname><given-names>DA</given-names></name>, <name><surname>Cushing</surname><given-names>CC</given-names></name>, <name><surname>Fritz</surname><given-names>A</given-names></name>, <name><surname>Amaro</surname><given-names>CM</given-names></name>, <name><surname>Ortega</surname><given-names>A</given-names></name>. <article-title>Mobile health interventions for improving health outcomes in youth: A meta-analysis</article-title>. <source>JAMA Pediatr</source>. <year>2017</year><month>May</month><day>1</day>;<volume>171</volume>(<issue>5</issue>):<fpage>461</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamapediatrics.2017.0042</pub-id>
<?supplied-pmid 28319239?><pub-id pub-id-type="pmid">28319239</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Camacho</surname><given-names>E</given-names></name>, <name><surname>Appelboom</surname><given-names>G</given-names></name>, <name><surname>Dumont</surname><given-names>E</given-names></name>, <name><surname>Taylor</surname><given-names>B</given-names></name>, <name><surname>Connolly</surname><given-names>E</given-names></name>. <article-title>The Ubiquitous Role of Smartphones in Mobile Health</article-title>. <source>Biometrics &amp; Biostatistics International Journal</source>. <year>2014</year>;<volume>1</volume>(<issue>1</issue>).</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Carmody</surname><given-names>JK</given-names></name>, <name><surname>Denson</surname><given-names>LA</given-names></name>, <name><surname>Hommel</surname><given-names>KA</given-names></name>. <article-title>Content and usability evaluation of medication adherence mobile applications for use in pediatrics</article-title>. <source>J Pediatr Psychol</source>. <year>2019</year><month>Apr</month><day>1</day>;<volume>44</volume>(<issue>3</issue>):<fpage>333</fpage>–<lpage>42</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/jpepsy/jsy086</pub-id>
<?supplied-pmid 30358863?><pub-id pub-id-type="pmid">30358863</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Jupp</surname><given-names>JCY</given-names></name>, <name><surname>Sultani</surname><given-names>H</given-names></name>, <name><surname>Cooper</surname><given-names>CA</given-names></name>, <name><surname>Peterson</surname><given-names>KA</given-names></name>, <name><surname>Truong</surname><given-names>TH</given-names></name>. <article-title>Evaluation of mobile phone applications to support medication adherence and symptom management in oncology patients</article-title>. <source>Pediatr Blood Cancer</source>. <year>2018</year><month>Nov</month>;<volume>65</volume>(<issue>11</issue>):<fpage>e27278</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/pbc.27278</pub-id><?supplied-pmid 29943893?><pub-id pub-id-type="pmid">29943893</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><collab>Vanderbilt University</collab>. <article-title>Project REDCap [Internet]</article-title>. <source>REDCap: Research Electronic Data Capture</source>. <year>2023</year> [cited 2022 Aug 8]. Available from: <ext-link xlink:href="https://www.project-redcap.org/" ext-link-type="uri">https://www.project-redcap.org/</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref036">
                <label>36</label>
                <mixed-citation publication-type="book"><collab>Vaica</collab>. <part-title>Medy RPM Proactive Remote Patient Management [Internet]</part-title>. <publisher-name>Vaica</publisher-name>. <year>2023</year> [cited 2023 Feb 1]. Available from: <ext-link xlink:href="https://www.vaica.com/medy-rpm/" ext-link-type="uri">https://www.vaica.com/medy-rpm/</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref037">
                <label>37</label>
                <mixed-citation publication-type="book"><collab>AARDEX Group</collab>. <source>MEMS ® Ecosystem [Internet]</source>. <publisher-name>AARDEX Group</publisher-name>. <year>2023</year> [cited 2023 Aug 8]. Available from: <ext-link xlink:href="https://www.aardexgroup.com/solutions/mems-adherence-hardware/" ext-link-type="uri">https://www.aardexgroup.com/solutions/mems-adherence-hardware/</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Blaschke</surname><given-names>TF</given-names></name>, <name><surname>Osterberg</surname><given-names>L</given-names></name>, <name><surname>Vrijens</surname><given-names>B</given-names></name>, <name><surname>Urquhart</surname><given-names>J</given-names></name>. <article-title>Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories</article-title>. <source>Annu Rev Pharmacol Toxicol</source>. <year>2012</year>;<volume>52</volume>:<fpage>275</fpage>–<lpage>301</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev-pharmtox-011711-113247</pub-id>
<?supplied-pmid 21942628?><pub-id pub-id-type="pmid">21942628</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>van Heuckelum</surname><given-names>M</given-names></name>, <name><surname>van den Ende</surname><given-names>CHM</given-names></name>, <name><surname>Houterman</surname><given-names>AEJ</given-names></name>, <name><surname>Heemskerk</surname><given-names>CPM</given-names></name>, <name><surname>van Dulmen</surname><given-names>S</given-names></name>, <name><surname>van den Bemt</surname><given-names>BJF</given-names></name>. <article-title>The effect of electronic monitoring feedback on medication adherence and clinical outcomes: A systematic review.</article-title><source>PLoS One.</source><year>2017</year><month>Oct</month><day>9</day>;<volume>12</volume>(<issue>10</issue>):<fpage>e0185453</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0185453</pub-id><?supplied-pmid 28991903?><pub-id pub-id-type="pmid">28991903</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Shah</surname><given-names>N</given-names></name>, <name><surname>Adusumalli</surname><given-names>S</given-names></name>. <article-title>Nudges and the meaningful adoption of digital health.</article-title><source>Per Med.</source><year>2020</year><month>Nov</month>;<volume>17</volume>(<issue>6</issue>):<fpage>429</fpage>–<lpage>33</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2217/pme-2020-0071</pub-id>
<?supplied-pmid 33026296?><pub-id pub-id-type="pmid">33026296</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Asch</surname><given-names>DA</given-names></name>, <name><surname>Muller</surname><given-names>RW</given-names></name>, <name><surname>Volpp</surname><given-names>KG</given-names></name>. <article-title>Automated hovering in health care—watching over the 5000 hours</article-title>. <source>N Engl J Med</source>. <year>2012</year><month>Jul</month><day>5</day>;<volume>367</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>3</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMp1203869</pub-id>
<?supplied-pmid 22716935?><pub-id pub-id-type="pmid">22716935</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Modi</surname><given-names>AC</given-names></name>, <name><surname>Pai</surname><given-names>AL</given-names></name>, <name><surname>Hommel</surname><given-names>KA</given-names></name>, <name><surname>Hood</surname><given-names>KK</given-names></name>, <name><surname>Cortina</surname><given-names>S</given-names></name>, <name><surname>Hilliard</surname><given-names>ME</given-names></name>, <etal>et al</etal>. <article-title>Pediatric self-management: a framework for research, practice, and policy</article-title>. <source>Pediatrics</source>. <year>2012</year><month>Feb</month>;<volume>129</volume>(<issue>2</issue>):<fpage>e473</fpage>–<lpage>85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1542/peds.2011-1635</pub-id>
<?supplied-pmid 22218838?><pub-id pub-id-type="pmid">22218838</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Skeens</surname><given-names>M</given-names></name>, <name><surname>Sezgin</surname><given-names>E</given-names></name>, <name><surname>Stevens</surname><given-names>J</given-names></name>, <name><surname>Landier</surname><given-names>W</given-names></name>, <name><surname>Pai</surname><given-names>A</given-names></name>, <name><surname>Gerhardt</surname><given-names>C</given-names></name>. <article-title>An mHealth app to promote adherence to immunosuppressant medication and track symptoms in children after hematopoietic stem cell transplant: Protocol for a mixed methods usability study.</article-title><source>JMIR Res Protoc</source>. <year>2022</year><month>Jul</month><day>21</day>;<volume>11</volume>(<issue>7</issue>):<fpage>e39098</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/39098</pub-id><?supplied-pmid 35862184?><pub-id pub-id-type="pmid">35862184</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Doherty</surname><given-names>K</given-names></name>, <name><surname>Balaskas</surname><given-names>A</given-names></name>, <name><surname>Doherty</surname><given-names>G</given-names></name>. <article-title>The design of Ecological Momentary Assessment technologies.</article-title><source>Interact Comput.</source><year>2020</year><month>May</month><day>17</day>;<volume>32</volume>(<issue>3</issue>):<fpage>257</fpage>–<lpage>78</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref045">
                <label>45</label>
                <mixed-citation publication-type="book"><collab>The Collaborative Institutional Training Initiative</collab>. <source>Research, Ethics, and Compliance Training [Internet]</source>. <publisher-name>The Collaborative Institutional Training Initiative (CITI Program).</publisher-name><year>2023</year> [cited 2022 Aug 8]. Available from: <ext-link xlink:href="https://about.citiprogram.org/" ext-link-type="uri">https://about.citiprogram.org/</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Brooke</surname><given-names>J.</given-names></name><article-title>SUS -A quick and dirty usability scale [Internet].</article-title><year>1995</year> [cited 2023 Apr 21]. Available from: <ext-link xlink:href="http://www.tbistafftraining.info/smartphones/documents/b5_during_the_trial_usability_scale_v1_09aug11.pdf" ext-link-type="uri">http://www.tbistafftraining.info/smartphones/documents/b5_during_the_trial_usability_scale_v1_09aug11.pdf</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Sauro</surname><given-names>J.</given-names></name><article-title>Measuring Usability with the System Usability Scale (SUS) [Internet]</article-title>. <source>MeasuringU</source>. <year>2011</year> [cited 2023 Apr 21]. Available from: <ext-link xlink:href="https://measuringu.com/sus/" ext-link-type="uri">https://measuringu.com/sus/</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Gov</surname><given-names>U.</given-names></name><article-title>System Usability Scale (SUS) [Internet]</article-title>. <ext-link xlink:href="https://usability.gov" ext-link-type="uri">usability.gov</ext-link>. <year>2023</year> [cited 2023 Apr 21]. Available from: <ext-link xlink:href="https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html#:~:text=Based%20on%20research%2C%20a%20SUS,to%20produce%20a%20percentile%20ranking" ext-link-type="uri">https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html#:~:text=Based%20on%20research%2C%20a%20SUS,to%20produce%20a%20percentile%20ranking</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref049">
                <label>49</label>
                <mixed-citation publication-type="book"><name><surname>Lewis</surname><given-names>JR</given-names></name>, <name><surname>Sauro</surname><given-names>J</given-names></name>. <part-title>The factor structure of the system usability scale.</part-title><source>In: Human Centered Design</source>. <publisher-loc>Berlin, Heidelberg</publisher-loc>: <publisher-name>Springer Berlin Heidelberg</publisher-name>; <year>2009</year>. p. <fpage>94</fpage>–<lpage>103</lpage>. (Lecture notes in computer science).</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><collab>Lumivero</collab>. <article-title>Lumivero [Internet].</article-title><source>NVivo: Unlock Insights with Qualitative Data Analysis Software</source>. <year>2023</year> [cited 2023 Aug 8]. Available from: <ext-link xlink:href="https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home?creative=605555104699&amp;keyword=nvivo&amp;matchtype=e&amp;network=g&amp;device=c&amp;gclid=CjwKCAjw6MKXBhA5EiwANWLODByZxOFy-dVTYzwIECVxrq4IQgX1ZFpKOiH2YiaBLBz1j8oT7u35jBoCtPsQAvD_BwE" ext-link-type="uri">https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home?creative=605555104699&amp;keyword=nvivo&amp;matchtype=e&amp;network=g&amp;device=c&amp;gclid=CjwKCAjw6MKXBhA5EiwANWLODByZxOFy-dVTYzwIECVxrq4IQgX1ZFpKOiH2YiaBLBz1j8oT7u35jBoCtPsQAvD_BwE</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref051">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Braun</surname><given-names>V</given-names></name>, <name><surname>Clarke</surname><given-names>V</given-names></name>. <article-title>Using thematic analysis in psychology.</article-title><source>Qual Res Psychol.</source><year>2006</year><month>Jan</month>;<volume>3</volume>(<issue>2</issue>):<fpage>77</fpage>–<lpage>101</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref052">
                <label>52</label>
                <mixed-citation publication-type="journal"><name><surname>Maguire</surname><given-names>M</given-names></name>, <name><surname>Delahunt</surname><given-names>B</given-names></name>. <article-title>Doing a thematic analysis: A practical, step-by-step guide for learning and teaching scholars</article-title>. <source>All Ireland Journal of Higher Education</source>. <year>2017</year>;<volume>9</volume>(<issue>3</issue>).</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref053">
                <label>53</label>
                <mixed-citation publication-type="journal"><name><surname>Sezgin</surname><given-names>E</given-names></name>, <name><surname>Noritz</surname><given-names>G</given-names></name>, <name><surname>Lin</surname><given-names>S</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>. <article-title>Feasibility of a Voice-Enabled Medical Diary App (SpeakHealth) for Caregivers of Children With Special Health Care Needs and Health Care Providers: Mixed Methods Study.</article-title><source>JMIR Form Res.</source><year>2021</year><month>May</month><day>11</day>;<volume>5</volume>(<issue>5</issue>):<fpage>e25503</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2196/25503</pub-id><?supplied-pmid 33865233?><pub-id pub-id-type="pmid">33865233</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref054">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Miloh</surname><given-names>T</given-names></name>, <name><surname>Barton</surname><given-names>A</given-names></name>, <name><surname>Wheeler</surname><given-names>J</given-names></name>, <name><surname>Pham</surname><given-names>Y</given-names></name>, <name><surname>Hewitt</surname><given-names>W</given-names></name>, <name><surname>Keegan</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Immunosuppression in pediatric liver transplant recipients: Unique aspects.</article-title><source>Liver Transpl</source>. <year>2017</year><month>Feb</month>;<volume>23</volume>(<issue>2</issue>):<fpage>244</fpage>–<lpage>56</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/lt.24677</pub-id>
<?supplied-pmid 27874250?><pub-id pub-id-type="pmid">27874250</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref055">
                <label>55</label>
                <mixed-citation publication-type="journal"><name><surname>El-Rachidi</surname><given-names>S</given-names></name>, <name><surname>LaRochelle</surname><given-names>JM</given-names></name>, <name><surname>Morgan</surname><given-names>JA</given-names></name>. <article-title>Pharmacists and pediatric medication adherence: Bridging the gap.</article-title><source>Hosp Pharm.</source><year>2017</year><month>Feb</month>;<volume>52</volume>(<issue>2</issue>):<fpage>124</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1310/hpj5202-124</pub-id>
<?supplied-pmid 28321139?><pub-id pub-id-type="pmid">28321139</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref056">
                <label>56</label>
                <mixed-citation publication-type="journal"><name><surname>Fitch</surname><given-names>T</given-names></name>, <name><surname>Myers</surname><given-names>KC</given-names></name>, <name><surname>Dewan</surname><given-names>M</given-names></name>, <name><surname>Towe</surname><given-names>C</given-names></name>, <name><surname>Dandoy</surname><given-names>C</given-names></name>. <article-title>Pulmonary complications after pediatric stem cell transplant</article-title>. <source>Front Oncol</source>. <year>2021</year><month>Oct</month><day>13</day>;<volume>11</volume>:<fpage>755878</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fonc.2021.755878</pub-id><?supplied-pmid 34722309?><pub-id pub-id-type="pmid">34722309</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref057">
                <label>57</label>
                <mixed-citation publication-type="journal"><name><surname>Ho</surname><given-names>M</given-names></name>, <name><surname>Bryson</surname><given-names>C</given-names></name>, <name><surname>Rumsfield</surname><given-names>J</given-names></name>. <article-title>Medication Adherence: It’s importance in cardiovascular outcomes</article-title>. <source>Circulation</source>. <year>2009</year>;<volume>119</volume>:<fpage>3028</fpage>–<lpage>35</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.768986</pub-id>
<?supplied-pmid 19528344?><pub-id pub-id-type="pmid">19528344</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref058">
                <label>58</label>
                <mixed-citation publication-type="journal"><name><surname>Khera</surname><given-names>N</given-names></name>, <name><surname>Zeliadt</surname><given-names>SB</given-names></name>, <name><surname>Lee</surname><given-names>SJ</given-names></name>. <article-title>Economics of hematopoietic cell transplantation</article-title>. <source>Blood</source>. <year>2012</year><month>Aug</month><day>23</day>;<volume>120</volume>(<issue>8</issue>):<fpage>1545</fpage>–<lpage>51</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1182/blood-2012-05-426783</pub-id>
<?supplied-pmid 22700725?><pub-id pub-id-type="pmid">22700725</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref059">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Robiner</surname><given-names>WN</given-names></name>. <article-title>Enhancing adherence in clinical research</article-title>. <source>Contemp Clin Trials</source>. <year>2005</year><month>Feb</month>;<volume>26</volume>(<issue>1</issue>):<fpage>59</fpage>–<lpage>77</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cct.2004.11.015</pub-id>
<?supplied-pmid 15837453?><pub-id pub-id-type="pmid">15837453</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref060">
                <label>60</label>
                <mixed-citation publication-type="journal"><name><surname>Hampl</surname><given-names>SE</given-names></name>, <name><surname>Borner</surname><given-names>KB</given-names></name>, <name><surname>Dean</surname><given-names>KM</given-names></name>, <name><surname>Papa</surname><given-names>AE</given-names></name>, <name><surname>Cordts</surname><given-names>KP</given-names></name>, <name><surname>Smith</surname><given-names>TR</given-names></name>, <etal>et al</etal>. <article-title>Patient attendance and outcomes in a structured weight management program</article-title>. <source>The Journal of pediatrics</source>. <year>2016</year>;<volume>176</volume>:<fpage>30</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">27289497</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0289987.ref061">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>CS</given-names></name>, <name><surname>Janicke</surname><given-names>DM</given-names></name>. <article-title>Barriers related to delivering pediatric weight management interventions to children and families from rural communities.</article-title><source>Child Health Care.</source><year>2013</year><month>Jul</month>;<volume>42</volume>(<issue>3</issue>):<fpage>214</fpage>–<lpage>30</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0289987.ref062">
                <label>62</label>
                <mixed-citation publication-type="journal"><collab>Pew Research Center</collab>. <article-title>Mobile Fact Sheet [Internet]</article-title>. <source>Demographics of Mobile Device Ownership and Adoption in the United States</source>. <year>2021</year> [cited 2023 Apr 20]. Available from: <ext-link xlink:href="https://www.pewresearch.org/internet/fact-sheet/mobile/" ext-link-type="uri">https://www.pewresearch.org/internet/fact-sheet/mobile/</ext-link></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
